Skip to main content
In stock|Cellular Therapy

Sipuleucel-T

Oncology TypeSolid Tumour (Prostate)
Drug Class / MechanismAutologous Cellular Immunotherapy
No Image
Description

Sipuleucel-T is classified as an Autologous Cellular Immunotherapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryCellular Therapy
Oncology TypeSolid Tumour (Prostate)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3